Showing results (11-20 of 139) with videos related to
Sort By:
Pageof 14
Blood|May 1, 1983
Lithium is an ineffective therapy for human cyclic hematopoiesisW P Hammond, B Berman, D G Wright, et al.Blood|May 15, 1990
Hematopoietic progenitors in cyclic neutropenia: effect of granulocyte colony-stimulating factor in vivoA R Migliaccio, G Migliaccio, D C Dale, et al.Blood|May 15, 1992
Abnormal responsiveness of granulocyte-committed progenitor cells in cyclic neutropeniaW P Hammond, G S Chatta, R G Andrews, et al.The New England Journal of Medicine|May 18, 1989
Treatment of cyclic neutropenia with granulocyte colony-stimulating factorW P Hammond, T H Price, L M Souza, et al.Blood|August 1, 1990
A comparison of treatment of canine cyclic hematopoiesis with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF interleukin-3, and canine G-CSFW P Hammond, T C Boone, R E Donahue, et al.Blood|January 1, 1995
Long-term treatment of canine cyclic hematopoiesis with recombinant canine stem cell factorD C Dale, E Rodger, J Cebon, et al.Journal of Gerontology|September 1, 1993
Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3G S Chatta, R G Andrews, E Rodger, et al.Experimental Hematology|September 1, 1988
Suppression of in vitro granulocytopoiesis by captopril and penicillamineW P Hammond, J E Miller, G Starkebaum, et al.The Journal of Clinical Investigation|February 1, 1991
Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factorW P Hammond, E Csiba, A Canin, et al.Blood|May 15, 1993
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropeniaD C Dale, M A Bonilla, M W Davis, et al.Pageof 14